General Announcement::Announcement by TMC Life Sciences Berhad - Q1 FY2025 Results Announcement

Issuer & Securities

Issuer/ Manager
THOMSON MEDICAL GROUP LIMITED
Securities
THOMSON MED S$120M5.5%N280531 - SGXF52537366 - V2AB
THOMSON MED S$175M4.05%N250128 - SGXF89249654 - RMEB
THOMSON MEDICAL GROUP LIMITED - SG1M49904634 - A50
THOMSON MED S$160M4.65%N291029 - SGXF42557540 - 9BQB
THOMSON MED S$155M5.25%N270513 - SGXF30304939 - HUHB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
18-Nov-2024 18:08:45
Status
New
Announcement Sub Title
Announcement by TMC Life Sciences Berhad - Q1 FY2025 Results Announcement
Announcement Reference
SG241118OTHRTGO0
Submitted By (Co./ Ind. Name)
Dr Heng Jun Li Melvin
Designation
Executive Director and Group CEO
Description (Please provide a detailed description of the event in the box below)
Please refer to the attached.

Attachments

TMCLS Announcement - Q1 FY2025.pdf
Total size =203K